Report #2898295

Received May 29, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: AZ
Recovered: Not recovered
Vaccinated: May 18, 2026
Onset: May 18, 2026
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	2	—	IM

Symptoms (1)

Dizziness

Symptom narrative

dizziness/ light-headed while standing up since 8 days; This non-serious case was reported by a consumer via call center representative and described the occurrence of light headedness in a 79-year-old female patient who received Herpes zoster (Shingrix) solution for injection for prophylaxis. On 18-MAY-2026, the patient received the 2nd dose of Shingrix (intramuscular, unknown arm) .5 ml. On 18-MAY-2026, less than a day after receiving Shingrix, the patient experienced light headedness (Verbatim: dizziness/ light-headed while standing up since 8 days). The outcome of the light headedness was not resolved. It was unknown if the reporter considered the light headedness to be related to Shingrix. Additional Information: GSK Receipt Date: 26-MAY-2026 The batch number was not provided upon follow- up with the reporter.